For agencies and consultancies

Offer your clients social listening and AI visibility without building a team.

Show your clients what patients, clinicians and AI assistants say about their brand and its competitors, so their brand plans, launches and congress strategy rest on evidence. You present the findings; Starling runs the listening behind you.

Talk to us about partner terms See a sample report

Add the capability without the headcount

Your client wants social listening or AI visibility. You don't have the team for it in-house.

Doing it alone

Hiring analysts, licensing a listening platform, building a taxonomy and learning the pharmacovigilance rules before the first report goes out.

With Starling

A complete programme under your name from the first month: a landscape study, then reports on the rhythm your client chooses.

Case study

Competitive monitoring in reproductive medicine, run behind a prime

Challenge: A consultancy needed a digital intelligence layer for an ongoing programme spanning six companies across three continents.
Delivered: Continuous social media monitoring with AI-assisted classification across ten themes. Monthly briefings, share of voice, alerts and annual factbook contributions.
Result: The consultancy now offers its clients digital intelligence without hiring social media analysts or licensing monitoring platforms.

Keep the relationship yours

You own the client. How the work splits is agreed once, at the start.

Doing it alone

Bringing in a specialist supplier who needs their own line to your client.

With Starling

We stay behind you. We never contact your client directly and join the debrief only when you invite us. White-label or co-branded, decided per client.

You

Own the relationship. Brief the questions. Present the findings, under your name or with ours on the cover.

Starling

Run the platform, read the conversation, produce the outputs. Join the debrief if you want us there; stay invisible if you do not.

Together

Agree the question bank, the comparator set, the adverse-event protocol with your client's safety team, and whose name goes where.

Give clients evidence they can trust

Pharma clients check how the numbers were made. Our method has been refined since 2012, with adverse-event handling built in.

Doing it alone

Dashboards your client has to interpret, and numbers that don't say what they count.

With Starling

One question per page, every figure with its base, and adverse events screened to your client's protocol. Every output is built to be shared and included in strategic deliverables.

Case study

A yearly benchmark of pharma on social media

Challenge: Pharmaceutical companies wanted to know how their corporate social media presence compared with their peers, on evidence rather than impressions.
Delivered: An annual benchmark covering 28 companies and 31 accounts, 700,000 followers in 55 audience groups, and a million posts classified by theme.
Result: Successive editions were bought by two of the ten largest pharmaceutical companies, and the segmentation became the base of the classifier Starling still runs.

How the partnership runs

The same programme our brand clients get, with you in front.

Step 1

Scope

Shape the questions with your client and agree the safety protocol up front, so you walk in prepared.

Step 2

Landscape

A full twelve-month baseline you can present as your opening deliverable.

Step 3

Calibrate

A session to sharpen the questions with your client. We join, or brief you to run it yourself.

Ongoing

Track

Monthly or quarterly updates that keep your client informed and coming back, under your name.

Three ways to work with us

A study, a subscription, or both, for each of your clients.

Study only

Fixed fee

Best when your client needs a baseline or a one-time answer before a launch or congress.

Subscription only

Annual, priced by rhythm: quarterly or monthly

Best when your client wants tracking from now on; we build a lighter baseline in the first month.

Study + subscription

Fixed fee, then annual

Best when your client wants the full picture first, then every month measured against it.

Subscriptions include the platform licence, adverse-event handling and language reading. Partner terms apply to work contracted through an agency.

Add Japan to any programme

Japan is the market agencies find hardest to staff. When your client's programme has a Japan gap, we add the Japanese patient and competitor conversation, read in Japanese by people who know the market.

How we safeguard patients and keep you compliant

Patients stay protected

We read public conversation only. Closed groups, gated patient networks and login-only forums stay private.
No private individual is ever named in a report. We cite organisations and public figures, and lightly paraphrase patient posts.
When a question needs patient interviews, we hand it to a primary-research partner, ours or yours, with a brief built from the listening.

Your client stays compliant

Trained readers screen for adverse events continuously and forward them under your client's pharmacovigilance protocol on business days.
Source links sit in an internal appendix under the agreed protocol, so the circulated report stays clean.
Patients and clinicians are separated by classification.

You know what to expect

Senior people read and interpret every report themselves, with automation doing the heavy lifting. The people you brief are the people who do the analysis, from scoping to the last report.
Your client relationship stays yours. We join a debrief or the pharmacovigilance set-up only when you invite us.

Get in touch

Starling GmbH
Zurich, Switzerland

The person who reads this is the person who runs the work. Expect a reply from one of us, not a form letter.

Kevin on LinkedIn Nina on LinkedIn